162 related articles for article (PubMed ID: 25247380)
21. Synthesis and evaluation of duocarmycin SA analogs incorporating the methyl 1,2,8,8a-tetrahydrocyclopropa[c]oxazolo[2,3-e]indol-4-one-6-carboxylate (COI) alkylation subunit.
Boyle KE; MacMillan KS; Ellis DA; Lajiness JP; Robertson WM; Boger DL
Bioorg Med Chem Lett; 2010 Mar; 20(6):1854-7. PubMed ID: 20171886
[TBL] [Abstract][Full Text] [Related]
22. Specific adenine alkylation by pyrrole-imidazole CBI conjugates.
Bando T; Narita A; Sasaki S; Sugiyama H
J Am Chem Soc; 2005 Oct; 127(40):13890-5. PubMed ID: 16201810
[TBL] [Abstract][Full Text] [Related]
23. Enantio- and diastereoselective synthesis of duocarmycine-based prodrugs for a selective treatment of cancer by epoxide opening.
Tietze LF; Schuster HJ; Hampel SM; Rühl S; Pfoh R
Chemistry; 2008; 14(3):895-901. PubMed ID: 18033701
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of 1,2,8, 8a-Tetrahydrocyclopropa[c]pyrrolo[3,2-e]indol-4(5H)-one, the parent alkylation subunit of CC-1065 and the duocarmycins: impact of the alkylation subunit substituents and its implications for DNA alkylation catalysis.
Boger DL; Santillán A; Searcey M; Brunette SR; Wolkenberg SE; Hedrick MP; Jin Q
J Org Chem; 2000 Jun; 65(13):4101-11. PubMed ID: 10866627
[TBL] [Abstract][Full Text] [Related]
25. Novel analogues of CC-1065 and the duocarmycins for the use in targeted tumour therapies.
Tietze LF; Krewer B
Anticancer Agents Med Chem; 2009 Mar; 9(3):304-25. PubMed ID: 19275523
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and anticancer activity of benzoselenophene and heteroaromatic derivatives of 1,2,9,9a-tetrahydrocyclopropa[c]benzo[e]indol-4-one (CBI).
Mhetre AB; Lee H; Yang H; Lee K; Nam DH; Lim D
Org Biomol Chem; 2017 Feb; 15(5):1198-1208. PubMed ID: 28090614
[TBL] [Abstract][Full Text] [Related]
27. Efficient DNA alkylation by a pyrrole-imidazole CBI conjugate with an indole linker: sequence-specific alkylation with nine-base-pair recognition.
Bando T; Sasaki S; Minoshima M; Dohno C; Shinohara K; Narita A; Sugiyama H
Bioconjug Chem; 2006; 17(3):715-20. PubMed ID: 16704209
[TBL] [Abstract][Full Text] [Related]
28. Total synthesis and evaluation of iso-duocarmycin SA and iso-yatakemycin.
MacMillan KS; Nguyen T; Hwang I; Boger DL
J Am Chem Soc; 2009 Jan; 131(3):1187-94. PubMed ID: 19154178
[TBL] [Abstract][Full Text] [Related]
29. Solid-Phase Synthesis of Duocarmycin Analogues and the Effect of C-Terminal Substitution on Biological Activity.
Stephenson MJ; Howell LA; O'Connell MA; Fox KR; Adcock C; Kingston J; Sheldrake H; Pors K; Collingwood SP; Searcey M
J Org Chem; 2015 Oct; 80(19):9454-67. PubMed ID: 26356089
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of a thio analogue of duocarmycin SA.
MacMillan KS; Lajiness JP; Cara CL; Romagnoli R; Robertson WM; Hwang I; Baraldi PG; Boger DL
Bioorg Med Chem Lett; 2009 Dec; 19(24):6962-5. PubMed ID: 19879753
[TBL] [Abstract][Full Text] [Related]
31. Substituent effects within the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065.
Boger DL; Stauffer F; Hedrick MP
Bioorg Med Chem Lett; 2001 Aug; 11(15):2021-4. PubMed ID: 11454471
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of antibody conjugates of phosphate prodrugs of cytotoxic DNA alkylators for the targeted treatment of cancer.
Zhao RY; Erickson HK; Leece BA; Reid EE; Goldmacher VS; Lambert JM; Chari RV
J Med Chem; 2012 Jan; 55(2):766-82. PubMed ID: 22148292
[TBL] [Abstract][Full Text] [Related]
33. CBI-CDPBO1 and CBI-CDPBI1: CC-1065 analogs containing deep-seated modifications in the DNA binding subunit.
Boger DL; Yun W; Cai H; Han N
Bioorg Med Chem; 1995 Jun; 3(6):761-7. PubMed ID: 7582954
[TBL] [Abstract][Full Text] [Related]
34. An efficient synthesis of hydropyrido[1,2-a]indole-6(7H)-ones via an In(III)-catalyzed tandem cyclopropane ring-opening/Friedel-Crafts alkylation sequence.
Patil DV; Cavitt MA; Grzybowski P; France S
Chem Commun (Camb); 2011 Oct; 47(37):10278-80. PubMed ID: 21860850
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological studies of different duocarmycin based glycosidic prodrugs for their use in the antibody-directed enzyme prodrug therapy.
Tietze LF; Schuster HJ; Krewer B; Schuberth I
J Med Chem; 2009 Jan; 52(2):537-43. PubMed ID: 19143570
[TBL] [Abstract][Full Text] [Related]
36. Rational design, synthesis, and evaluation of key analogues of CC-1065 and the duocarmycins.
Tichenor MS; MacMillan KS; Stover JS; Wolkenberg SE; Pavani MG; Zanella L; Zaid AN; Spalluto G; Rayl TJ; Hwang I; Baraldi PG; Boger DL
J Am Chem Soc; 2007 Nov; 129(45):14092-9. PubMed ID: 17948994
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of duocarmycin SA analogs incorporating the methyl 1,2,8,8a-tetrahydrocyclopropa[c]imidazolo[4,5-e]indol-4-one-6-carboxylate (CImI) alkylation subunit.
Chanda PB; Boyle KE; Brody DM; Shukla V; Boger DL
Bioorg Med Chem; 2016 Oct; 24(20):4779-4786. PubMed ID: 27221071
[TBL] [Abstract][Full Text] [Related]
38. Cyclization of free radicals at the C-7 position of ethyl indole-2-carboxylate derivatives: an entry to a new class of Duocarmycin Analogues.
Al-Said NH; Shawakfeh KQ; Abdullah WN
Molecules; 2005 Dec; 10(12):1446-57. PubMed ID: 18007541
[TBL] [Abstract][Full Text] [Related]
39. Asymmetric synthesis and biological evaluation of glycosidic prodrugs for a selective cancer therapy.
Tietze LF; von Hof JM; Krewer B; Müller M; Major F; Schuster HJ; Schuberth I; Alves F
ChemMedChem; 2008 Dec; 3(12):1946-55. PubMed ID: 19021160
[TBL] [Abstract][Full Text] [Related]
40. An additional spirocyclization for duocarmycin SA.
MacMillan KS; Boger DL
J Am Chem Soc; 2008 Dec; 130(49):16521-3. PubMed ID: 19554689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
